Evaluation of as an adjuvant therapy in the management of (thalassemia major).

Introduction: Thalassemia major is a malignant type of genetic disorder and iron overload is the main complication of the disease which results due to frequent blood transfusions. has been proved effective against iron overload in experimental studies and pilot voluntary study, hence, taken for clinical evaluation in the present study.

Aim: The aim of this study is to evaluate the efficacy of as an adjuvant therapy in the management of thalassemia major.